Andrew Aromando

Chief Operating Officer, Ambrx Biopharma Cayman, Inc.

Companies

Oncolytics BiotechChief Business Officer Jan 2, 2026 to now¹
Ambrx Biopharma, Inc.Chief operating officer Dec 11, 2023 to Mar 7, 2024²
Ambrx Biopharma Cayman, Inc.Chief operating officer May 5, 2023 to Jul 7, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Oncolytics Biotech ONCY55,100 shares⁴$27.7K at $0.50Feb 11, 2026
Ambrx Biopharma, Inc.109,263 shares⁵Dec 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 11, 2026Bought 29,600 shares at $0.86 of Oncolytics Biotech⁴
Dec 11, 2023Granted 100,000 shares of Ambrx Biopharma, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROncolytics Biotech, Chief Business Officer
2
SEC EDGARAmbrx Biopharma, Inc., Chief operating officer
3
SEC EDGARAmbrx Biopharma Cayman, Inc., Chief operating officer
4
SEC EDGAROncolytics Biotech shares after the filing of Feb 11, 2026
5
SEC EDGARAmbrx Biopharma, Inc. shares after the filing of Dec 11, 2023